Cao Y - Search Results

1

Translation of the circular RNA circβ-catenin promotes liver cancer cell growth through activation of the Wnt pathway.

Liang WC, Wong CW, Liang PP, Shi M, Cao Y, Rao ST, Tsui SK, Waye MM, Zhang Q, Fu WM, Zhang JF. Liang WC, et al. Among authors: cao y. Genome Biol. 2019 Apr 26;20(1):84. doi: 10.1186/s13059-019-1685-4. Genome Biol. 2019. PMID: 31027518 Free PMC article.

2

A phase I clinical trial of an adenovirus-mediated endostatin gene (E10A) in patients with solid tumors.

Lin X, Huang H, Li S, Li H, Li Y, Cao Y, Zhang D, Xia Y, Guo Y, Huang W, Jiang W. Lin X, et al. Among authors: cao y. Cancer Biol Ther. 2007 May;6(5):648-53. doi: 10.4161/cbt.6.5.4004. Epub 2007 Feb 13. Cancer Biol Ther. 2007. PMID: 17426445 Free article. Clinical Trial.

3

[A randomized control clinical trial of Euruikang (docetaxel) in treatment of advanced non-small cell lung cancer (NSCLC)].

Cao Y, Wang ZQ, Guo Y, Feng FY, Hu XH, Xiong JP, Tang GD, Guan ZZ, Zhang L. Cao Y, et al. Ai Zheng. 2006 Aug;25(8):999-1002. Ai Zheng. 2006. PMID: 16965682 Clinical Trial. Chinese.

4

Serum C-reactive protein as an important prognostic variable in patients with diffuse large B cell lymphoma.

Cao Y, Shi YX, Chen JO, Tan YT, Cai YC, Luo HY, Qiu MZ, Cai XY, Jin Y, Sun YL, Jiang WQ. Cao Y, et al. Tumour Biol. 2012 Aug;33(4):1039-44. doi: 10.1007/s13277-012-0337-z. Epub 2012 Feb 11. Tumour Biol. 2012. PMID: 22328138

5

Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.

Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Chen QJ, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Su YH, Hua X, Wang XY, Hong RX, Jiang KK, Song CG, Huang ZZ, Shi W, Zhong YY, Yuan ZY; South China Breast Cancer Group (SCBCG). Wang X, et al. Among authors: cao y. JAMA. 2021 Jan 5;325(1):50-58. doi: 10.1001/jama.2020.23370. JAMA. 2021. PMID: 33300950 Free PMC article. Clinical Trial.

6

Changes in clinical trials of cancer drugs in mainland China over the decade 2009-18: a systematic review.

Li N, Huang HY, Wu DW, Yang ZM, Wang J, Wang JS, Wang SH, Fang H, Yu Y, Bai Y, Yan Z, Cao Y, Jiang M, Liu YF, Li KY, Xu BH, Sun Y, He J. Li N, et al. Among authors: cao y. Lancet Oncol. 2019 Nov;20(11):e619-e626. doi: 10.1016/S1470-2045(19)30491-7. Lancet Oncol. 2019. PMID: 31674320

7

Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma.

Yang H, Jiang WQ, Cao Y, Sun YA, Wei J, An X, Zhang YC, Song M, Wang SS, Yuan ZY, Peng RJ, Chen TH, Li LR, Shi YX. Yang H, et al. Among authors: cao y. Dis Markers. 2015;2015:640263. doi: 10.1155/2015/640263. Epub 2015 Apr 29. Dis Markers. 2015. PMID: 26063961 Free PMC article.

8

Does Routine Anti-Osteoporosis Medication Lower the Risk of Fractures in Male Subjects? An Updated Systematic Review With Meta-Analysis of Clinical Trials.

Zeng LF, Pan BQ, Liang GH, Luo MH, Cao Y, Guo D, Chen HY, Pan JK, Huang HT, Liu Q, Guan ZT, Han YH, Zhao D, Zhao JL, Hou SR, Wu M, Lin JT, Li JH, Liang WX, Ou AH, Wang Q, Yang WY, Liu J. Zeng LF, et al. Among authors: cao y. Front Pharmacol. 2019 Aug 9;10:882. doi: 10.3389/fphar.2019.00882. eCollection 2019. Front Pharmacol. 2019. PMID: 31447677 Free PMC article.

9

Is adjunctive treatment with medication of liver-soothing-oriented method beneficial for depression after cerebrovascular accident?: A PRISMA-compliant meta-analysis.

Zeng LF, Liang WX, Liu JC, Chen XY, Du WY, Li ZP, Wang Q, Cao Y, Wang L, Meng CR, Wang KZ, Wang NS. Zeng LF, et al. Among authors: cao y. Medicine (Baltimore). 2016 Nov;95(44):e5208. doi: 10.1097/MD.0000000000005208. Medicine (Baltimore). 2016. PMID: 27858863 Free PMC article.

10

Effectiveness of capecitabine with or without docetaxel therapy for the treatment of patients with advanced urothelial carcinoma: a single-institution experience.

Xue C, An X, Cao Y, Chen T, Yang W, Deng Y, Han H, Teng X, Zhou F, Shi Y. Xue C, et al. Among authors: cao y. Oncotarget. 2016 Sep 27;7(39):63722-63729. doi: 10.18632/oncotarget.11641. Oncotarget. 2016. PMID: 27577082 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,919 results

Search Page

Filters